Tech Company Financing Transactions

Tokai Pharmaceuticals Funding Round

Queensland Investment Corporation joined a $9.3 million capital raise for Tokai Pharmaceuticals . The round was announced on 6/30/2007.

Transaction Overview

Announced On
6/30/2007
Transaction Type
Venture Equity
Amount
$9,264,900
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
255 State St. 6th floor
Boston, MA 02109
USA
Email Address
Not Recorded
Overview
Tokai Pharmaceuticals (NASDAQ: TKAI) develops biopharmaceutical products that focus on endocrine treatment. The company is developing novel, proprietary therapies for prostate cancer and other hormonally-driven diseases.
Profile
Tokai Pharmaceuticals  LinkedIn Company Profile
Social Media
Tokai Pharmaceuticals  Company Twitter Account
Company News
Tokai Pharmaceuticals  News
Facebook
Tokai Pharmaceuticals  on Facebook
YouTube
Tokai Pharmaceuticals  on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jodie Morrison
  Jodie Morrison LinkedIn Profile  Jodie Morrison Twitter Account  Jodie Morrison News  Jodie Morrison on Facebook
Chief Operating Officer
John McBride
  John McBride LinkedIn Profile  John McBride Twitter Account  John McBride News  John McBride on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2007: MongoNet venture capital transaction
Next: 6/30/2007: 3point5.com venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary